Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bicaudal D cargo adaptor 1 (BICD1) is an evolutionarily conserved cytoskeletal motor adaptor protein that facilitates the loading and transport of intracellular cargo via the dynein/dynactin complex, playing crucial roles in microtubule organization, vesicular trafficking, and cell polarity. BICD1 is characterized by conserved coiled-coil domains facilitating cargo binding and interaction with molecular motors. It regulates the intracellular sorting and recycling of neurotrophin receptors (TrkB and p75^NTR^) in neurons, and modulates signaling by affecting receptor location and turnover, impacting neurotrophic factor responses and neuronal development. BICD1 also interacts with cellular signaling proteins such as PAR1, affecting the signaling pathways and promoting receptor endocytosis. Under hypoxic conditions, it is essential for HIF1α nuclear translocation. Its dysfunction has been implicated in diseases such as emphysema, otitis media, central corneal ulcer, and cancer progression. There is no evidence of BICD1 being a direct drug target or associated with approved therapeutics.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bicaudal D cargo adaptor 1 (BICD1).